Please login to the form below

Research Pipeline

This page shows the latest Research Pipeline news and features for those working in and with pharma, biotech and healthcare.

Sanofi sheds jobs in R&D restructuring

make a meaningful difference for patients and to maximise the productivity of our research engine.”. ... It has 84 projects in its pipeline, with oncology accounting for 26 projects.

Latest news

Merck KGaA exec takes top job at UK biotech Kymab

With its competitive antibody research platforms and evolving clinical pipeline, Kymab is well positioned as it progresses into an integrated discovery and development company.”. ... The company’s most advanced pipeline candidate is KY1005, a
AZ signs $20m deal with Seres for microbiome project

AstraZeneca is funding a research project at Seres Therapeutics to explore how the bacteria in the gut can affect – and possible enhance – the effect of cancer immunotherapies. ... Just last month, the company announced it would cut a third of its
CRUK forges £30m ‘post-Brexit’ R&D alliance

No single organisation or country is going to beat cancer on its own,” commented Dr Iain Foulkes, executive director of research and innovation at CRUK. ... Our Accelerator Award funding will lay the groundwork for a Europe and UK research pipeline,
GSK: we won’t be splitting up any time soon

The company has 27 immunomodulatory new molecular entities (NME) in clinical trials, around 60% of its total clinical pipeline. ... GSK is investing $300m in the firm, and says a long-term partnership to exploit its genetic databases will help it advance
Daily Brief: GSK unveils R&D plan, Keytruda OK'd for lymphoma by NICE

News from pharma, biotech and healthcare. 23andMe alliance part of GSK’s new research plan. ... GSK’s CEO Emma Walmsley (pictured) has restated her determination to revive the firm’s research pipeline in a statement this morning, ahead of an

More from news
Approximately 3 fully matching, plus 44 partially matching documents found.

Latest Intelligence

Heart failure therapy embarks on a new era

There are also a number of other drugs coming through the research pipelines. ... Pipeline growing. While Entresto and ivabradine promise to make a significant impact in HF, there are also a number of other investigational drugs coming through the
Eisai: Bucking the trend with R&D growth

Research pipeline. Research at Eisai is focused on three key areas: neuroscience, oncology and vascular/immunological diseases. . ... Commercial expansion. But it's not just in research spending that Eisai is bucking industry trends.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

Sigma-Tau Pharmaceuticals appoints CEO

a time of development in the company, as it expands through registration, life-cycle management and commercialisation of its proprietary research and development pipeline.
Adaptimmune appoints former GSK executives

He will also lead the development of the company's pipeline of research programmes.
MedDay appoints former Sanofi VP to board

MedDay, which was only formed in 2011, will welcome Goupit's knowledge of business development as it looks to expand with its pipeline of drugs for nervous system disorders such as ... Goupit said: “I strongly believe that MedDay's product pipeline and
Galapagos appoints Bart Filius as chief financial officer

As we move forward and the pipeline matures further, I look forward to bringing my experience in finance and M&A to Galapagos.”. ... pipeline company” to a research-focused biotech firm.

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Medical Writer/ Senior Medical Writer opportunities – Macclesfie...: competitive salary and benefits package

Senior Medical Writer: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

My MS journey: one patient's search for innovation: David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.: Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?: Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...